Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_provenance.
- NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_assertion description "[AVI-4126, a neutral antisense phosphorodiamidate morpholino oligomer (PMO) has been identified to specifically inhibit c-MYC expression in multiple disease models and identified in Phase I clinical studies to be safe and bioavailable in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_provenance.
- NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_assertion evidence source_evidence_literature NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_provenance.
- NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_assertion SIO_000772 18096271 NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_provenance.
- NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_assertion wasDerivedFrom befree-2016 NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_provenance.
- NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_assertion wasGeneratedBy ECO_0000203 NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_provenance.
- befree-2016 importedOn "2016-02-19" NP646514.RAl07QpmdnlHOA2lTGe2j8wIXW5DjX5rMY7jZ977ookgs130_provenance.